A safety analysis of edaravone (MCI-186) during the first...

A safety analysis of edaravone (MCI-186) during the first six cycles (24 weeks) of amyotrophic lateral sclerosis (ALS) therapy from the double-blind period in three randomized, placebo-controlled studies

Kalin, Alexander, Medina-Paraiso, Elvia, Ishizaki, Kaoru, Kim, Alex, Zhang, Yannong, Saita, Takanori, Wasaki, Masahiko
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
DOI:
10.1080/21678421.2017.1362440
Date:
October, 2017
File:
PDF, 491 KB
english, 2017
Conversion to is in progress
Conversion to is failed